Skip to content

The Immediate Effects of Tissue Flossing on Knee Flexion Range of Motion

The Immediate Effects of Tissue Flossing on Knee Flexion Range of Motion: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06205069
Enrollment
58
Registered
2024-01-12
Start date
2024-02-15
Completion date
2024-03-29
Last updated
2024-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The purpose of this study is to verify the immediate effects of Tissue Flossing on knee flexion range of motion

Detailed description

After completing the questionnaire, 58 healthy participants will be randomly divided into two groups named Intervention Group (IG) (n=29) and Control Group (CG) (n=29). In the first assessment (M0), knee flexion ranges will be measured using a goniometer. Then the control group (n=29), without Tissue Flossing and intervention group (n=29) with Tissue Flossing around the knee joint will be subjected to passive and then active mobilization of the knee joint. Immediately after the intervention/control, the two groups will be assessed again (M1).

Interventions

While the participant will stand and perform a slight knee flexion, the band will be rolled upwards from the tibial tuberosity to 5 cm above the femoral epicondyle. The patella will not be covered. Pressure will be produced by rolling the joint with 50% tension and 50% overlap.

Sponsors

University Fernando Pessoa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy people between 18 and 35 years old with normal mobility of the joints of the lower limbs of the body.

Exclusion criteria

* deformities in the region of the lower limbs of the body, complaints in this region in the last 6 months, surgical procedures, venous thrombotic disease, heart disease, respiratory disease, or neurological, orthopedic, dermatitis, or neuromuscular problems in the lower quadrant that may disrupt musculoskeletal function. Also high blood pressure, latex allergies, lymphedema and individuals taking anticoagulant medication, and cortisteroid therapy.

Design outcomes

Primary

MeasureTime frameDescription
Change of knee range of motion[Time Frame: Change from Baseline (M0) to Immediately after intervention or control (M1)]Data will be collected in two moments: baseline (M0) and after the intervention/control (M1). The knee flexion range of motion will be measured using a smartphone app Goniometer Pro. The distance between the lateral femoral epicondyle and the center of the lateral malleolus will be assessed. To measure the knee flexion angle, the participant will be placed in the prone position with the hip and knee extended at 0° (goniometer initial position 0°) with the foot relaxed and the contralateral leg extended. For active range of motion, the participant will be asked to perform maximum knee flexion in the prone position. To measure passive movement, the examiner will perform maximum knee flexion on participants in the same position. The average of three repetitions of ranges of movement will be recorded with 30-second rest intervals.

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026